Geode Capital Management
KPRX icon

Geode Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Geode Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.3K Buy
47,850
+25,840
+117% +$54.5K ﹤0.01% 4152
2025
Q4 		$43.4K Buy
22,010
+3,157
+17% +$7.2K ﹤0.01% 4261
2025
Q3 		$52.8K Buy
18,853
+280
+2% +$769 ﹤0.01% 4278
2025
Q2 		$53.5K Buy
18,573
+226
+1% +$689 ﹤0.01% 4202
2025
Q1 		$55.2K Buy
18,347
+2,390
+15% +$8.3K ﹤0.01% 4179
2024
Q4 		$53.8K Buy
15,957
+1,474
+10% +$5.09K ﹤0.01% 4232
2024
Q3 		$53K Buy
14,483
+712
+5% +$2.78K ﹤0.01% 4255
2024
Q2 		$57.8K Buy
13,771
+9,636
+233% +$45K ﹤0.01% 4253
2024
Q1 		$26.3K Hold
4,135
– – ﹤0.01% 4443
2023
Q4 		$19.7K Hold
4,135
– – ﹤0.01% 4517
2023
Q3 		$21.9K Buy
+4,135
New +$21.2K ﹤0.01% 4610
2022
Q4 		– Sell
-1,556
Closed -$86K – 4914
2022
Q3 		$86K Buy
1,556
+36
+2% +$2.81K ﹤0.01% 4624
2022
Q2 		$257K Buy
1,520
+48
+3% +$8.03K ﹤0.01% 4121
2022
Q1 		$329K Buy
1,472
+17
+1% +$4.45K ﹤0.01% 4142
2021
Q4 		$791K Buy
1,455
+795
+120% +$448K ﹤0.01% 3823
2021
Q3 		$534K Buy
660
+619
+1,510% +$526K ﹤0.01% 4004
2021
Q2 		$53K Hold
41
– – ﹤0.01% 4649
2021
Q1 		$73K Buy
41
+6
+17% +$13.1K ﹤0.01% 4352
2020
Q4 		$62K Sell
35
-62
-64% -$85.5K ﹤0.01% 4130
2020
Q3 		$137K Hold
97
– – ﹤0.01% 3825
2020
Q2 		$168K Buy
97
+1
+1% +$1.88K ﹤0.01% 3702
2020
Q1 		$179K Buy
96
+2
+2% +$4.3K ﹤0.01% 3580
2019
Q4 		$337K Buy
+94
New +$182K ﹤0.01% 3634

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Geode Capital Management's KPRX Position: Q1 2026 in Review

Geode Capital Management increased its Kiora Pharmaceuticals (KPRX) stake by 117% in Q1 2026, buying an estimated $54.5K and bringing the position to 47,850 shares worth $92.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4152.

Geode Capital Management first reported a position in KPRX in Q4 2019 and has held it in 23 quarters since. The position peaked at $791K in Q4 2021. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • Geode Capital Management held 47,850 shares of Kiora Pharmaceuticals worth $92.3K as of Q1 2026.
  • Geode Capital Management bought 25,840 Kiora Pharmaceuticals shares in Q1 2026, an estimated $54.5K.
  • Kiora Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4152 holding.
  • Geode Capital Management first reported a position in Kiora Pharmaceuticals in Q4 2019 and has held it in 23 quarters since.
  • Geode Capital Management's Kiora Pharmaceuticals position peaked at $791K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.